GLP Digest

GLP Digest

The latest news on GLP-1 drugs, the industry, and R&D. Subscribe now to get a curated summary sent to your inbox each week.

Archive

Eli Lilly goes direct; NIH study of Semaglutide shows no link to suicidal thoughts

Eli Lilly goes direct; NIH study of Semaglutide shows no link to suicidal thoughts

Shortages in UK until 2025; snacking replaced with shopping; more

GLP Digest
GLP Digest
Equinox joins the club to support GLP-1 members. Is partial cost coverage coming?

Equinox joins the club to support GLP-1 members. Is partial cost coverage coming?

Impact of Semaglutide on T2D; Tirzepatide leads to allergic reaction from Semaglutide patients; more

GLP Digest
GLP Digest
New GLP-1 Pill Shows Promise in Trials; Patients Pausing Treatment for the Holidays

New GLP-1 Pill Shows Promise in Trials; Patients Pausing Treatment for the Holidays

+ WeightWatchers jumps in, new drug shows promise, and more

GLP Digest
GLP Digest
Bernie Targets GLP-1 Drugs; Top 5 Reasons Users Discontinued Semaglutide

Bernie Targets GLP-1 Drugs; Top 5 Reasons Users Discontinued Semaglutide

Link between Semaglutide and Rhabdomyolysis + 2 more stories

GLP Digest
GLP Digest
Weight Loss Drugs Boost Apparel Sales; Semaglutide's Role in Alcohol Use Disorder

Weight Loss Drugs Boost Apparel Sales; Semaglutide's Role in Alcohol Use Disorder

+ Watchdogs review links to suicide; Pfizer discontinues drug; and more

GLP Digest
GLP Digest
Why is Eli Lilly Giving Mounjaro a Second Name?

Why is Eli Lilly Giving Mounjaro a Second Name?

+ Novo Sacrificing Other Drugs; revised anesthesia guidelines; 2 more stories

GLP Digest
GLP Digest